U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222254) titled 'A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222280) titled 'Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy' on July 21. Brief... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222098) titled 'A Clinical Study of MK-1084 With Rosuvastatin and Metformin in Healthy People (MK-1084-016)... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222111) titled 'Prebiotics (Dried Plum) and Immune Function in Postmenopausal Women' on Sept. 01. Brief Su... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222228) titled 'A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Fe... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222085) titled 'Long-Term Stability of the Glide Control Strategy' on Oct. 27. Brief Summary: This researc... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222189) titled 'A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in P... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222449) titled 'Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disrupt... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222358) titled 'Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform ... Read More
U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222137) titled 'A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Chil... Read More